IRIS Accounts Production v24.3.0.553 06089796 Board of Directors Board of Directors 1.4.23 31.3.24 31.3.24 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh060897962023-03-31060897962024-03-31060897962023-04-012024-03-31060897962022-03-31060897962022-04-012023-03-31060897962023-03-3106089796ns15:EnglandWales2023-04-012024-03-3106089796ns14:PoundSterling2023-04-012024-03-3106089796ns10:Director12023-04-012024-03-3106089796ns10:Director22023-04-012024-03-3106089796ns10:PrivateLimitedCompanyLtd2023-04-012024-03-3106089796ns10:SmallEntities2023-04-012024-03-3106089796ns10:AuditExempt-NoAccountantsReport2023-04-012024-03-3106089796ns10:SmallCompaniesRegimeForDirectorsReport2023-04-012024-03-3106089796ns10:SmallCompaniesRegimeForAccounts2023-04-012024-03-3106089796ns10:FullAccounts2023-04-012024-03-310608979612023-04-012024-03-3106089796ns5:CurrentFinancialInstruments2024-03-3106089796ns5:CurrentFinancialInstruments2023-03-3106089796ns5:Non-currentFinancialInstruments2024-03-3106089796ns5:Non-currentFinancialInstruments2023-03-3106089796ns5:ShareCapital2024-03-3106089796ns5:ShareCapital2023-03-3106089796ns5:RetainedEarningsAccumulatedLosses2024-03-3106089796ns5:RetainedEarningsAccumulatedLosses2023-03-3106089796ns10:RegisteredOffice2023-04-012024-03-3106089796ns5:NetGoodwill2023-04-012024-03-3106089796ns5:IntangibleAssetsOtherThanGoodwill2023-04-012024-03-3106089796ns5:NetGoodwill2023-03-3106089796ns5:NetGoodwill2024-03-3106089796ns5:NetGoodwill2023-03-3106089796ns5:PlantMachinery2023-03-3106089796ns5:PlantMachinery2023-04-012024-03-3106089796ns5:PlantMachinery2024-03-3106089796ns5:PlantMachinery2023-03-3106089796ns5:PlantMachineryns5:LeasedAssetsHeldAsLessee2023-03-3106089796ns5:PlantMachineryns5:LeasedAssetsHeldAsLessee2023-04-012024-03-3106089796ns5:PlantMachineryns5:LeasedAssetsHeldAsLessee2024-03-3106089796ns5:PlantMachineryns5:LeasedAssetsHeldAsLessee2023-03-3106089796ns5:CurrentFinancialInstrumentsns5:WithinOneYear2024-03-3106089796ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-03-31
REGISTERED NUMBER: 06089796 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2024

FOR

WINDOW MEDIC YNYS MON LIMITED

WINDOW MEDIC YNYS MON LIMITED (REGISTERED NUMBER: 06089796)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024










Page

Balance Sheet 1

Notes to the Financial Statements 3


WINDOW MEDIC YNYS MON LIMITED (REGISTERED NUMBER: 06089796)

BALANCE SHEET
31 MARCH 2024

2024 2023
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 10,917 12,130
Tangible assets 5 89,625 81,554
100,542 93,684

CURRENT ASSETS
Stocks 23,438 19,603
Debtors 6 31,396 42,660
Cash at bank and in hand 160,013 134,074
214,847 196,337
CREDITORS
Amounts falling due within one year 7 200,031 189,672
NET CURRENT ASSETS 14,816 6,665
TOTAL ASSETS LESS CURRENT
LIABILITIES

115,358

100,349

CREDITORS
Amounts falling due after more than one
year

8

-

(7,200

)

PROVISIONS FOR LIABILITIES (20,255 ) (15,495 )
NET ASSETS 95,103 77,654

CAPITAL AND RESERVES
Called up share capital 100 100
Retained earnings 95,003 77,554
SHAREHOLDERS' FUNDS 95,103 77,654

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

WINDOW MEDIC YNYS MON LIMITED (REGISTERED NUMBER: 06089796)

BALANCE SHEET - continued
31 MARCH 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Profit and Loss Account has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 1 November 2024 and were signed on its behalf by:




Mrs J Hamilton - Director



S Hamilton - Director


WINDOW MEDIC YNYS MON LIMITED (REGISTERED NUMBER: 06089796)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024


1. STATUTORY INFORMATION

Window Medic Ynys Mon Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number: 06089796

Registered office: Brittania House, Four Crosses
Menai Bridge
Anglesey
LL59 5RW

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover represents net invoiced work done and uninvoiced amounts due on contracts by reference to the stage of completion, excluding value added tax.

Goodwill
Goodwill, being the amount paid in connection with the acquisition of a business in 2007, is being amortised evenly over its estimated useful life of twenty five years.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life or, if held under a finance lease, over the lease term, whichever is shorter.
Plant and Machinery - 20% on reducing balance
Motor Vehicles - 15% on reducing balance
Computer Equipment - Straight line over 3 years

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Profit and Loss Account, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


WINDOW MEDIC YNYS MON LIMITED (REGISTERED NUMBER: 06089796)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2024


2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Assets obtained under hire purchase contracts or finance leases are capitalised in the balance sheet. Those held under hire purchase contracts are depreciated over their estimated useful lives. Those held under finance leases are depreciated over their estimated useful lives or the lease term, whichever is the shorter.

The interest element of these obligations is charged to profit or loss over the relevant period. The capital element of the future payments is treated as a liability.

Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 14 (2023 - 11 ) .

4. INTANGIBLE FIXED ASSETS
Goodwill
£   
COST
At 1 April 2023
and 31 March 2024 30,330
AMORTISATION
At 1 April 2023 18,200
Charge for year 1,213
At 31 March 2024 19,413
NET BOOK VALUE
At 31 March 2024 10,917
At 31 March 2023 12,130

WINDOW MEDIC YNYS MON LIMITED (REGISTERED NUMBER: 06089796)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2024


5. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 April 2023 167,316
Additions 27,245
Disposals (23,226 )
At 31 March 2024 171,335
DEPRECIATION
At 1 April 2023 85,762
Charge for year 16,012
Eliminated on disposal (20,064 )
At 31 March 2024 81,710
NET BOOK VALUE
At 31 March 2024 89,625
At 31 March 2023 81,554

Fixed assets, included in the above, which are held under hire purchase contracts are as follows:

Plant and
machinery
etc
£   
COST
At 1 April 2023
and 31 March 2024 39,485
DEPRECIATION
At 1 April 2023 15,015
Charge for year 3,671
At 31 March 2024 18,686
NET BOOK VALUE
At 31 March 2024 20,799
At 31 March 2023 24,470

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade debtors 9,433 36,056
Amounts recoverable on contract 21,963 6,604
31,396 42,660

WINDOW MEDIC YNYS MON LIMITED (REGISTERED NUMBER: 06089796)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2024


7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Hire purchase contracts 7,200 7,218
Trade creditors 83,091 108,305
Taxation and social security 46,614 19,969
Other creditors 63,126 54,180
200,031 189,672

8. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
2024 2023
£    £   
Hire purchase contracts - 7,200